je.st
news
Tag: biotech
Amgen wins approval for second biotech cholesterol drug
2015-08-31 08:29:18| Biotech - Topix.net
This undated image provided by Amgen Inc. shows Repatha. Amgen Inc. has won federal approval for the second medicine in a new class of pricey biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades.
Tags: drug
approval
wins
biotech
Biotech corporation withdraws application to release GM flies in...
2015-08-29 22:42:58| Biotech - Topix.net
Environmental and civil society groups gained a victory in early August when British biotechnology company Oxitec withdrew its application to perform outdoor experiments using genetically modified olive flies in Spain. Nevertheless, the groups warn that with recent advances in genetic engineering technology, more efforts to modify the genomes of wild species are likely just around the corner.
Tags: in
application
release
corporation
UM seeking $10 million from the county to expand its biotech park
2015-08-28 06:36:58| Biotech - Topix.net
The University of Miami wants to expand its Life Science & Technology Park- and it wants county taxpayers to help pay for it. The university, through its partner developer, Wexford Miami LLC, is asking the county for $10 million in economic development grants.
Tags: park
million
county
expand
Amgen wins approval for second biotech cholesterol drug
2015-08-28 00:23:50| Biotech - Topix.net
" Amgen Inc. has won approval for the second medicine in a new class of biotech drugs that reduce artery-clogging cholesterol more than older statin drugs that have been used for decades. The drug Repatha could eventually help millions of Americans who face increased risks of heart disease because they cannot control their cholesterol with existing drugs.
Tags: drug
approval
wins
biotech
Premarket Biotech Digest: Valeant's M&A Prospects, Stocks Tumble, Novartis Promacta Extension
2015-08-25 23:15:17| Biotech - Topix.net
The iShares NASDAQ Biotechnology Index ETF fell another 4% on Monday and is now down more than 11% in the last three trading sessions amid a selloff in the broader market. Not surprisingly, the question every biotech focused investor is asking right now is whether this is an opportunity to buy.
Tags: extension
stocks
prospects
digest
Sites : [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] next »